Naming Malignant Angioendotheliomatosis

Thomas J. Carroll, Robert L. Schelper, James A. Goeken, John D. Kemp, Khalil Sheibani, Hector Battifora, Carl D. Winberg, Jerome S. Burke, Jonathan Ben-Ezra, Henry Rappaport

Research output: Contribution to journalLetterpeer-review

4 Scopus citations


To the Editor: We are pleased to note that the recent article by Sheibani et al. (April 10 issue)1 corroborates our previously reported findings that neoplastic angioendotheliomatosis actually represents an unusual form of malignant lymphoma. We have proposed that neoplastic angioendotheliomatosis be designated intravascular malignant lymphomatosis (IML), a term that we think best describes this entity.2 3 4 We prefer the use of IML to describe this entity because “angiotropic,” as used by Sheibani et al. and derived from Wrotnowski et al.,5 could be confused with a similar term, “angiocentric,” which has been applied to a group of atypical lymphoid proliferations that….

Original languageEnglish
Pages (from-to)895-896
Number of pages2
JournalNew England Journal of Medicine
Issue number14
StatePublished - 2 Oct 1986
Externally publishedYes


Dive into the research topics of 'Naming Malignant Angioendotheliomatosis'. Together they form a unique fingerprint.

Cite this